CDTX Company Profile and Key Details
Cidara Therapeutics, Inc.
CDTX Stock Price Chart
Stock Price Today
Cidara Therapeutics, Inc. (CDTX) stock declined over -0.86%, trading at $21.99 on NASDAQ, down from the previous close of $22.18. The stock opened at $22.00, fluctuating between $21.68 and $22.22 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.
Company Information
| Employees | 69 |
| Beta | 0.99 |
| Sales or Revenue | $63.91M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Cidara Therapeutics, Inc. (NASDAQ: CDTX) stock price is $21.99 in the last trading session. During the trading session, CDTX stock reached the peak price of $22.22 while $21.68 was the lowest point it dropped to. The percentage change in CDTX stock occurred in the recent session was -0.86% while the dollar amount for the price change in CDTX stock was -$0.19.
The NASDAQ listed CDTX is part of Biotechnology industry that operates in the broader Healthcare sector. Cidara Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Taylor Sandison
Chief Medical Officer
Dr. Kevin M. Forrest Ph.D.
Founder and Chief Strategy Officer
Ms. Carol Waldo
Senior Vice President of Regulatory Affairs & Quality Assurance
Mr. James M. Balkovec
Senior Vice President of Research
Ms. Laura A. Navalta
Senior Vice President of Clinical Operations
Dr. Les Tari Ph.D.
Chief Scientific Officer
Mr. Shane M. Ward
Chief Operating Officer & Chief Legal Officer
Dr. Preetam Shah M.B.A., Ph.D.
Chief Financial Officer, Chief Bus. Officer & Principal Accounting Officer
Dr. Leslie Tari Ph.D.
Chief Scientific Officer
Ms. Allison Lewis CCP, SPHR
Senior Vice President of People & Culture
Dr. Jeffrey L. Stein Ph.D.
Pres, Chief Executive Officer & Executive Director
CDTX's closing price is 119.9% higher than its 52-week low of $10.00 where as its distance from 52-week high of $28.42 is -22.62%.
Number of CDTX employees currently stands at 69.
Official Website of CDTX is: https://www.cidara.com
CDTX could be contacted at phone 858 752 6170 and can also be accessed through its website. CDTX operates from 6310 Nancy Ridge Drive, San Diego, CA 92121, United States.
CDTX stock volume for the day was 125.05K shares. The average number of CDTX shares traded daily for last 3 months was 79.48K.
The market value of CDTX currently stands at $240.68M with its latest stock price at $21.99 and 10.95M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com